Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Hematopoietic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00726830
What this trial is testing

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more
M.D. Anderson Cancer Center 1
Not applicableUnknownNCT03764228
What this trial is testing

Human Amniotic Epithelial Cells Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation

Who this might be right for
Acute-graft-versus-host Disease
Peking University People's Hospital 27
Not applicableLooking for participantsNCT06155188
What this trial is testing

Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia

Who this might be right for
LeukemiaStem Cell TransplantCord Blood
Nanfang Hospital, Southern Medical University 60
Testing effectiveness (Phase 2)UnknownNCT05413356
What this trial is testing

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Who this might be right for
Bronchiolitis Obliterans SyndromeHematologic Malignancy
First Affiliated Hospital of Zhejiang University 50
Not applicableStudy completedNCT04635397
What this trial is testing

Immunomonitoring After Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Centre Hospitalier Universitaire de Nice 61
Testing effectiveness (Phase 2)Study completedNCT03267186
What this trial is testing

Ibrutinib in Preventing Acute Leukemia in Patients After Reduced-Intensity Conditioning and Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaAcute Myeloid Leukemia+2 more
Andrew Rezvani 8
Not applicableUnknownNCT03593161
What this trial is testing

Humor Therapy and Distress After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Universitätsklinikum Hamburg-Eppendorf 126
Large-scale testing (Phase 3)Looking for participantsNCT07463651
What this trial is testing

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

Who this might be right for
Acute Myeloid Leukemia (AML)FLT3-ITD MutationAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more
The First Affiliated Hospital of Soochow University 594
Testing effectiveness (Phase 2)Looking for participantsNCT07572669
What this trial is testing

Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Steroid-Refractory Acute Graft-Versus-Host DiseaseAcute Graft-Versus-Host DiseaseGraft-Versus-Host Disease+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05873205
What this trial is testing

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00539695
What this trial is testing

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Who this might be right for
Acute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more
Baylor College of Medicine 25
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Early research (Phase 1)Looking for participantsNCT04013802
What this trial is testing

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.

Who this might be right for
Viral Infection
Baylor College of Medicine 47
Not applicableLooking for participantsNCT03357172
What this trial is testing

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Central Hospital, Nancy, France 700
Not applicableStudy completedNCT05766332
What this trial is testing

Evaluating Clinical Evaluation Tools for Predicting Risk of Complications After Hematopoietic Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
Mayo Clinic 137
Not applicableStudy completedNCT02492100
What this trial is testing

A Multimodal Intervention to Address Sexual Dysfunction in Hematopoietic Stem Cell Transplant Survivors

Who this might be right for
Sexual Dysfunction
Massachusetts General Hospital 47
Not applicableUnknownNCT05200338
What this trial is testing

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Testing effectiveness (Phase 2)Study completedNCT01525407
What this trial is testing

Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation

Who this might be right for
Malignant Neoplasm
Fred Hutchinson Cancer Center 83
Testing effectiveness (Phase 2)UnknownNCT05599256
What this trial is testing

Prevention of Severe Acute Graft-versus-host Disease in Pediatric Patients Using a daGOAT Model

Who this might be right for
Transplant-Related Disorder
Institute of Hematology & Blood Diseases Hospital, China 40
Next Page